Total Payments
$281,654
2024 Payments
$21,750
Companies
52
Transactions
1,285
Medicare Patients
5,510
Medicare Billing
$465,767
Payment Breakdown by Category
Other$171,355 (60.8%)
Consulting$52,511 (18.6%)
Food & Beverage$40,251 (14.3%)
Travel$17,420 (6.2%)
Education$117.66 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $171,355 | 80 | 60.8% |
| Consulting Fee | $52,511 | 10 | 18.6% |
| Food and Beverage | $40,251 | 1,131 | 14.3% |
| Travel and Lodging | $17,420 | 59 | 6.2% |
| Education | $117.66 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $114,608 | 209 | $0 (2024) |
| Edwards Lifesciences Corporation | $65,685 | 160 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $54,587 | 103 | $0 (2024) |
| Medtronic, Inc. | $22,904 | 255 | $0 (2024) |
| Medtronic Vascular, Inc. | $8,165 | 74 | $0 (2020) |
| Inari Medical, Inc. | $2,525 | 24 | $0 (2024) |
| Boston Scientific Corporation | $1,915 | 36 | $0 (2024) |
| Amgen Inc. | $1,464 | 56 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,015 | 59 | $0 (2024) |
| Abbott Laboratories | $1,009 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,750 | 201 | Edwards Lifesciences Corporation ($16,380) |
| 2023 | $27,034 | 192 | Edwards Lifesciences Corporation ($18,937) |
| 2022 | $34,023 | 178 | AstraZeneca Pharmaceuticals LP ($12,774) |
| 2021 | $40,958 | 154 | Edwards Lifesciences Corporation ($20,249) |
| 2020 | $21,425 | 101 | Janssen Pharmaceuticals, Inc ($9,347) |
| 2019 | $55,530 | 115 | Janssen Pharmaceuticals, Inc ($50,144) |
| 2018 | $38,961 | 150 | Janssen Pharmaceuticals, Inc ($23,191) |
| 2017 | $41,974 | 194 | Janssen Pharmaceuticals, Inc ($26,790) |
All Payment Transactions
1,285 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Structural Heart | ||||||
| 12/31/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Renal Denervation System | ||||||
| 12/27/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/23/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $39.67 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $31.65 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: Renal Denervation System | ||||||
| 12/17/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $40.73 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/16/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $125.08 | General |
| Category: Renal Denervation System | ||||||
| 12/10/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $98.95 | General |
| Category: VTE | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.53 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $103.40 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $132.05 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/21/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: Renal Denervation System | ||||||
| 11/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $79.99 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Renal Denervation System | ||||||
| 11/18/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/18/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/18/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: Transcatheter Valve Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,173 | 1,355 | $432,221 | $97,000 |
| 2022 | 22 | 1,410 | 1,746 | $520,671 | $117,404 |
| 2021 | 25 | 1,661 | 2,027 | $641,738 | $137,052 |
| 2020 | 24 | 1,266 | 1,463 | $516,370 | $114,311 |
Total Patients
5,510
Total Services
6,591
Medicare Billing
$465,767
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 35 | 35 | $123,020 | $20,392 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 264 | $69,762 | $15,531 | 22.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 102 | $34,527 | $9,533 | 27.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 137 | 141 | $28,251 | $7,555 | 26.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 33 | 33 | $28,131 | $6,642 | 23.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $22,695 | $5,936 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $16,900 | $4,359 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 47 | $17,612 | $4,120 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $17,073 | $3,901 | 22.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 23 | 24 | $13,992 | $3,628 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $10,388 | $2,571 | 24.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $10,438 | $2,566 | 24.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 303 | 389 | $9,336 | $2,475 | 26.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 38 | 38 | $8,501 | $2,268 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $7,384 | $1,954 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,632 | $1,226 | 26.5% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 17 | 17 | $3,569 | $743.93 | 20.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 44 | 44 | $2,714 | $726.88 | 26.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 45 | 45 | $1,860 | $491.85 | 26.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 17 | 17 | $918.00 | $244.63 | 26.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 14 | 14 | $518.00 | $137.20 | 26.5% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2022 | 35 | 35 | $123,233 | $21,001 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 232 | 273 | $70,847 | $16,209 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 77 | 172 | $50,866 | $13,806 | 27.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 23 | 26 | $45,031 | $11,185 | 24.8% |
About Dr. Ramzi Khalil, MD
Dr. Ramzi Khalil, MD is a Cardiovascular Disease healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790777829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramzi Khalil, MD has received a total of $281,654 in payments from pharmaceutical and medical device companies, with $21,750 received in 2024. These payments were reported across 1,285 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($171,355).
As a Medicare-enrolled provider, Khalil has provided services to 5,510 Medicare beneficiaries, totaling 6,591 services with total Medicare billing of $465,767. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Pittsburgh, PA
- Active Since 08/16/2005
- Last Updated 10/14/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790777829
Products in Payments
- XARELTO (Drug) $114,695
- BRILINTA (Drug) $54,083
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $43,912
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $16,151
- CoreValve Evolut (Device) $14,770
- COREVALVE EVOLUT R (Device) $12,365
- FLOWTRIEVER CATHETER, S (Device) $2,505
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $2,137
- ONYX FRONTIER (Device) $2,037
- SYMPLICITY G3 (Device) $1,123
- Repatha (Biological) $1,095
- SAPIEN 3 Ultra RESILIA (Device) $966.64
- ENTRESTO (Drug) $798.22
- LifeVest (Device) $636.16
- FFRct (Device) $562.54
- FARXIGA (Drug) $503.36
- Impella (Device) $498.03
- Barostim Neo System (Device) $495.47
- CARDIOHELP (Device) $419.07
- ELIQUIS (Drug) $393.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pittsburgh
Dr. John Chenarides, Md, MD
Cardiovascular Disease — Payments: $1.0M
Cardiovascular Disease $1.0M
Dr. George Gabriel, Do, DO
Cardiovascular Disease — Payments: $801,111
Cardiovascular Disease $801,111
Andrew Pogozelski, M.d, M.D
Cardiovascular Disease — Payments: $442,274
Cardiovascular Disease $442,274
Mark Greathouse, Md, MD
Cardiovascular Disease — Payments: $382,075
Cardiovascular Disease $382,075
David Lasorda, Do, DO
Cardiovascular Disease — Payments: $278,090
Cardiovascular Disease $278,090
Dr. Nathan Estes, M.d, M.D
Cardiovascular Disease — Payments: $146,656
Cardiovascular Disease $146,656